Bo Ding Selected Research

Doxorubicin (Adriamycin)

11/2008	ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes.
6/2008	Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Ding Research Topics

Disease

34	Neoplasms (Cancer) 04/2024 - 04/2010
22	Rheumatoid Arthritis 08/2014 - 09/2007
20	Type 2 Diabetes Mellitus (MODY) 01/2023 - 02/2011
15	Inflammation (Inflammations) 04/2024 - 06/2003
14	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2024 - 02/2012
11	Asthma (Bronchial Asthma) 12/2023 - 01/2017
10	Hearing Loss (Hearing Impairment) 04/2024 - 01/2016
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2017
5	Breast Neoplasms (Breast Cancer) 03/2024 - 11/2021
4	Insulin Resistance 10/2023 - 10/2006
4	Hypoglycemia (Reactive Hypoglycemia) 05/2021 - 12/2018
3	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 01/2023
3	Infections 01/2024 - 01/2014
3	Hypersensitivity (Allergy) 12/2023 - 04/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 10/2015
3	Leiomyoma (Uterine Fibroids) 12/2022 - 07/2019
3	Hypoxia (Hypoxemia) 01/2022 - 07/2009
3	Gliosis 01/2022 - 09/2020
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 03/2016
3	Glioblastoma (Glioblastoma Multiforme) 08/2012 - 04/2010
2	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 05/2009
2	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 01/2020
2	Vaginal Neoplasms (Cancer, Vaginal) 07/2023 - 01/2020
2	Osteoporosis 01/2022 - 01/2013
2	Dehydration (Water Stress) 01/2022 - 07/2014
2	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2020
2	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 11/2017
2	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2021 - 01/2021
2	Adenocarcinoma of Lung 01/2021 - 11/2020
2	Hyperglycemia 01/2021 - 04/2006
2	Virus Diseases (Viral Diseases) 11/2020 - 01/2013
2	Neuroinflammatory Diseases 10/2020 - 09/2020
2	Presbycusis 01/2020 - 11/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 03/2009
2	Atherosclerosis 04/2019 - 10/2003

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2012
13	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2009
11	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 02/2011
8	Anti-Citrullinated Protein AntibodiesIBA 08/2014 - 09/2007
7	Insulin (Novolin)FDA Link 10/2023 - 12/2018
7	Testosterone (Sustanon)FDA Link 10/2023 - 01/2019
6	Blood Glucose (Blood Sugar)IBA 10/2023 - 12/2018
5	Messenger RNA (mRNA)IBA 01/2023 - 04/2006
5	CytokinesIBA 07/2021 - 10/2003
4	Amino Acids FDA Link 04/2024 - 04/2005
4	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2022
4	MicroRNAs (MicroRNA)IBA 10/2023 - 06/2018
4	Long Noncoding RNAIBA 09/2023 - 01/2017
4	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 02/2011
4	Ion Channels (Ion Channel)IBA 01/2022 - 01/2018
4	AntigensIBA 03/2016 - 01/2009
3	crocinIBA 02/2024 - 01/2022
3	Peptides (Polypeptides)IBA 10/2023 - 12/2009
3	Indicators and Reagents (Reagents)IBA 10/2023 - 04/2010
3	Circular RNAIBA 10/2023 - 01/2021
3	AllergensIBA 01/2023 - 08/2012
3	Complement System Proteins (Complement)IBA 10/2022 - 04/2011
3	Particulate MatterIBA 09/2022 - 01/2021
3	EnzymesIBA 01/2022 - 08/2011
3	Mitogen-Activated Protein KinasesIBA 09/2020 - 01/2004
3	NF-kappa B (NF-kB)IBA 09/2020 - 06/2003
3	Muscarinic AntagonistsIBA 01/2020 - 01/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2019 - 10/2015
3	Protein Isoforms (Isoforms)IBA 01/2019 - 05/2006
3	AutoantibodiesIBA 08/2014 - 10/2008
3	EpitopesIBA 01/2013 - 04/2009
3	HLA-DRB1 Chains (HLA DRB1)IBA 01/2013 - 04/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2012 - 10/2003
3	AntibodiesIBA 02/2011 - 01/2009
2	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2022
2	InterferonsIBA 01/2024 - 12/2023
2	SmokeIBA 10/2023 - 03/2011
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2023 - 01/2020
2	6-methyladenineIBA 09/2023 - 10/2022
2	CarcinogensIBA 07/2023 - 01/2020
2	dapagliflozinIBA 01/2023 - 01/2020
2	bisphenol AIBA 12/2022 - 07/2019
2	Transcription Factors (Transcription Factor)IBA 12/2022 - 06/2003
2	Estrogens (Estrogen)FDA Link 12/2022 - 01/2019
2	LDL CholesterolIBA 01/2022 - 01/2016
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 05/2021
2	oxidized low density lipoproteinIBA 01/2022 - 10/2015
2	Hormones (Hormone)IBA 01/2022 - 01/2020
2	SuspensionsIBA 10/2021 - 10/2019
2	Air Pollutants (Pollutants, Air)IBA 06/2021 - 01/2021
2	Insulin Glargine (Lantus)FDA Link 01/2021 - 01/2020
2	pyridineIBA 11/2020 - 11/2020
2	tanshinoneIBA 10/2020 - 01/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2020 - 04/2019
2	Streptozocin (Streptozotocin)FDA Link 01/2020 - 04/2006
2	C-Reactive ProteinIBA 01/2019 - 11/2017

Therapy/Procedure

22	Therapeutics 03/2024 - 07/2010
4	Glycemic Control 10/2023 - 12/2018
4	Nebulizers and Vaporizers (Inhaler) 01/2019 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2024 - 12/2020
2	Lymph Node Excision (Lymph Node Dissection) 07/2023 - 01/2020
2	Hysterectomy 06/2023 - 10/2021
2	Immunotherapy 01/2023 - 01/2021
2	Aftercare (After-Treatment) 01/2023 - 07/2014
2	Photothermal Therapy 12/2020 - 01/2020